Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI may soon predict your breast cancer treatment success

NCT ID NCT05981326

Recruiting now Knowledge-focused Sponsor: Institut Cancerologie de l'Ouest Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting medical data, blood samples, and lifestyle information from 300 people with early breast cancer. The goal is to create a computer algorithm that can predict whether a patient will have a complete response to chemotherapy before they start treatment. This is not a treatment trial but a research project to improve personalized medicine.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a computer tool that helps doctors predict which breast cancer treatments will work best for each patient, improving outcomes.
What could go wrong
This is an early observational study, not testing a treatment. The algorithm may not be accurate enough for real-world use, and results may take years to validate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institut de Cancérologie de l'Ouest

    RECRUITING

    Angers, 49055, France

    Contact Email: •••••@•••••

  • Institut de Cancérologie de l'Ouest

    RECRUITING

    Saint-Herblain, 44805, France

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.